Torrent Pharmaceuticals consolidated net profit surged 51.71% to Rs 443 crore in Q3 FY24 as compared with Rs 292 crore in Q3 FY23.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.